Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-04-23

Clinical Trial Update: Morphine Mouthwash for Management of Oral Mucositis in Patients With Head and Neck Cancer [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating morphine mouthwash to manage oral mucositis in patients with head and neck cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Morphine mouthwash (morphine)

Snippet

Sponsor: Isfahan University of Medical Sciences | Conditions: Stomatitis | Phase 2, Phase 3 | Status: COMPLETED